Lotus Eye Hospital And Institute Ltd - 532998 - Financial Results Clarifications
Financial results clarifications29-05-2019
29-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report27/05/2019 3 Name of the Certifying Firm P. ESWARAMOORTHY AND COMPANY 4 Name of the Certifying Individual P. ESWARAMOORTHY 5Membership TypeFCS 6 Membership Number 6510 7 CP No. 7069 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes28-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Dividend Updates
After much deliberation, the management has decided not to declare dividends for the financial year ending 31st March, 2019.28-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Results - Financial Year Ending 31St March, 2019
Results - Financial year ending 31st March, 201928-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Outcome of Board Meeting
Outcome of the Board meeting held on 28/05/201928-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayLotus Eye Hospital And Institute Ltd 2CINL85110TZ1997PLC007783 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.09 4Highest Credit Rating during the previous FY na 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Aakanksha Parmar Designation: Company Secretary EmailId: [email protected] Name of the Chief Financial Officer: L. Sriram Designation: Chief Financial oFFICER EmailId: [email protected] Date: 21/05/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.21-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for Lotus Eye Hospital And Institute Ltd Has Informed BSE That The Meeting Of The Board Of Directors Of The Company Is Scheduled On 28/05/2019,Inter Alia, To Consider And Approve Audited Financial Results For The Quarter/Year Ending 31St March, 2019. To Consider Dividend For The Year Ended 31St March, 2019. Any Other Business
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2019 ,inter alia, to consider and approve Audited Financial Results for the Quarter/year ending 31st March, 2019. To consider dividend for the year ended 31st March, 2019. Any other business17-05-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Compliances - Reg40(10) - PCS Certificate For Transfer/Transmission/Transposition.
Compliances - Reg40(10) - PCS Certificate for transfer/Transmission/Transposition.17-04-2019
Lotus Eye Hospital And Institute Ltd - 532998 - Shareholding for the Period Ended March 31, 2019
Lotus Eye Hospital And Institute Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click here13-04-2019